BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 4.55 billion as of September 10, 2024. Its market cap has increased by 0.14% in one year.

Market Cap

4.55B

Enterprise Value

3.91B

Revenue

133.45M

Ranking

n/a

PE Ratio

n/a

Stock Price

37.00

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.55B, an increase of 67.55%. That is a compound annual growth rate of 10.36%.

Market Cap History

Date	Market Cap	% Change
Sep 10, 2024	4.55B	-3.40%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	2.44B	-9.97%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition